The United Kingdom became the first country to approve an anti-covid tablet on Thursday, Nove-4-2021. UK approved the use of Merck's Antiviral Medicine to treat patients with mild to moderate Coronavirus.

Health minister Sajid Javid said. ”Today is a historic moment for the United Kingdom, as the UK has become the first country in the world that has approved an antiviral pill that may be used at home to treat Covid-19,” 

"This will be transformative for the most vulnerable and immunocompromised patients, who will soon be able to get this ground-breaking treatment," he continued.

The antiviral molnupiravir works by impairing a virus's capacity to replicate, reducing the progression of the disease.
The Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom has approved molnupiravir for mild to moderate COVID-19 and at least one risk factor for serious illness, such as obesity, diabetes, old age, or heart disease.

Clinical trial data indicate that the medicine is most effective when used early in the illness. Therefore, the MHRA recommends that it be administered within five days of the commencement of symptoms.

It has been approved for use in those with at least one risk factor for serious illness, such as obesity, advanced age, diabetes, or heart disease.

Britain, one of the hardest-hit countries by the epidemic, stated on October 20 that it had placed an order with US pharmaceutical firm Merck for 480,000 pills of molnupiravir.

Regulators have previously evaluated medicine in the United States and the European Union.

Not a vaccination substitute

Merck has already struck agreements with several governments, including the United States, which intends to purchase 1.7 million doses if authorities approve molnupiravir.

June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, described the pill as "another therapy to add to our arsenal."

"It is also the first antiviral medication approved for this disease that may be taken orally rather than intravenously," she noted.

"This is critical since it allows for administration outside of a hospital setting."

According to Munir Pirmohamed, chair of the Commission on Human Medicines, clinical trials have shown that the medicine is 50% effective at reducing the likelihood of hospitalization or mortality in at-risk non-hospitalized persons.

However, specialists caution that the medication is not a cure-all, and Pirmohamed stated that it was not intended to be used in replacement of vaccination against the virus.

The government and the state-run National Health Service stated they will announce the treatment's rollout "in due course."

Since the onset of the epidemic, a simple pill to cure the coronavirus has been sought, and Merck's disclosure of its trial results was lauded as a significant step toward that aim.

Previously, Covid treatments such as monoclonal antibodies and Gilead's remdesivir – marketed in the EU as Veklury – were administered intravenously.

A team initially created Molnupiravir at Emory University in Atlanta, Georgia, as an inhibitor of influenza and respiratory syncytial virus, two additional acute severe respiratory illnesses.

Merck is also undertaking a separate clinical trial to evaluate the medicine for a second indication: preventing those in close contact with those infected from contracting the virus.

CORONAVIRUS UPDATED QUESTIONS AND ANSWERS | COVID-19 | 2021

You'll discover an answer to frequent questions that we all have below. As credible information becomes available, we will add additional questions and update responses.

NEW INQUIRIES AND RESPONSES OCTOBER 2021

CAN I RECEIVE MY FLU VACCINE AND MY COVID-19 BOOSTER DOSE AT THE SAME TIME?

The CDC states that you can have the COVID-19 vaccination plus another vaccine, such as the flu shot, at the same time. The CDC's recommendations apply to the first or booster dose of the COVID-19 vaccination.

Getting both vaccinations at the same time does not influence the efficacy of either immunization. Side effects are typically the same whether the vaccinations are administered simultaneously or individually. Of course, if the injections are given to separate limbs, you may have discomfort in both.

Many clinics now provide both vaccinations at the same time. As a result, it's recommended to get your flu vaccination before the end of October 2021.

IS A COVID VACCINATION BOOSTER INJECTION REQUIRED?

The CDC recommended a booster dose of the COVID-19 vaccine for specific Pfizer/BioNTech vaccine users in September 2021. The FDA approved to get a booster dosage in these populations earlier this month. Those eligible for a booster must wait at least six months after finishing the first two doses of the mRNA vaccination series before receiving the third injection.

The CDC specifically advises that the following populations receive a booster dose:

• People who are 65 and older.
• Residents in long-term care Settings.
• People aged 50 to 64 with undergoing medical problems that place them at a higher risk of severe COVID disease.

Furthermore, the CDC suggests that the following populations receive a booster dose:

People aged 18 and 49 who have underlying medical problems that place them at a higher risk of severe COVID disease because of their work or institutional context.

People aged 18 to 64 are at a higher risk of COVID-19 exposure and transmission.

Although the Pfizer/BioNTech vaccine is authorized for persons aged 16 and up, the CDC does not suggest a booster dose for 16- and 17-year-olds who have underlying medical problems. This might be because male teenagers and young adults have been reported to have a higher-than-normal risk of cardiac inflammation after receiving the mRNA COVID-19 vaccinations.

This booster prescription does not apply to those who received the first dose of the Modern or Johnson & Johnson vaccinations. Modern and Johnson & Johnson have both requested that the FDA approve booster doses of their respective vaccinations. In mid-October, the FDA will hold a meeting to examine these authorizations.

WHEN WILL THE COVID-19 VACCINATION BE AVAILABLE TO CHILDREN?

Pfizer/BioNTech's COVID-19 vaccination is safe and effective in children aged 5 to 11 years. Pfizer Vaccine has submitted its data to the FDA and requested emergency use authorization (EUA). The FDA will meet on October 26 to review the situation.

Children aged 5-11 received a lower dose of the COVID-19 vaccination than previously thought. Antibody responses and side effects were similar to those of 16-to-25-year-old participants in prior research. There were insufficient study instances to determine if the vaccination protected against infection or sickness.

The FDA expanded its EUA for the Pfizer and BioNTech COVID-19 vaccination to encompass adolescents aged 12 to 15 in May 2021. Previously, the Pfizer vaccination was approved for use in children aged 16 and up, while the Modern and Johnson & Johnson vaccinations were approved for individuals aged 18 and up.

Moderna applied to the FDA in June 2021 for a EUA of its mRNA vaccine for use in children aged 12 to under 18 years. In May, the firm revealed positive findings from a Phase 2/3 trial in teenagers. The research included 3,732 youngsters ranging in age from 12 to 17. Two-thirds were given two doses of the Moderna mRNA vaccine, while the remaining one-third received a placebo. The vaccine's immune reaction in teenagers was shown to be at least as good as the vaccine's immunological response in adults. In addition, there were no cases of COVID-19 in the vaccination group beginning two weeks after the second vaccine dose, compared to four cases in the placebo group. Vaccine adverse effects ranged from mild to serious, with the most frequent being injection site discomfort, headache, tiredness, muscular soreness, and chills.

There were no notable safety issues identified in the research. The findings were revealed in a news release. Moderna is also testing the vaccine on youngsters aged six months to 12 years. Age de-escalation studies, in which vaccinations are tested in groups of decreasing age children, are performed to validate that the vaccines are safe and efficacious for each age group. They also determine the appropriate dose, which must be beneficial while still having manageable adverse effects.

The FDA evaluates results from de-escalation studies to determine whether to approve vaccinations for each age group.

DOES THE CORONA VACCINE EFFECTIVE AGAINST LONG-TERM COVID?

Being completely Vaccinated with a COVID-19 vaccine reduces the chance of developing a lengthy COVID. Long COVID, also known as a post-COVID-19 syndrome or post-acute sequelae of SARS-CoV-2 infection (PASC), refers to symptoms that appear or continue longer than 28 days following initial COVID-19 infection.

In two methods, vaccination may lower the risk of long COVID. The first is to lower the likelihood of being infected with COVID in the first place. But what about those who get ill despite being vaccinated and have a breakthrough infection?

According to research published in The Lancet, fully vaccinated persons who suffer breakthrough infections are around 50% less likely to acquire protracted COVID than sick people but have not been vaccinated. These reports are based on self-reported data from the United Kingdom between December 2020 and July 2021 using the COVID Symptom Study phone app.

THE PFIZER/BIONTECH COVID-19 VACCINE HAS RECEIVED FULL CLEARANCE FROM THE FDA. WHAT DISTINGUISHES THIS FROM EMERGENCY USAGE AUTHORIZATION?

The FDA awarded final clearance to the Pfizer/BioNTech COVID-19 mRNA vaccine for use in persons aged 16 and above in August 2021. The vaccine's status was upgraded from emergency use authorizations (EUA) to the full licensing based on additional data and a more extended follow-up period demonstrating that it satisfied specific safety, efficacy, and manufacturing quality requirements. Comirnaty is the new commercial name for the Pfizer/BioNTech vaccine.

The FDA examined data from 44,000 trial participants before giving full permission. Half of the participants received two (2) doses of the Pfizer/BioNTech vaccine, while others received a placebo. The vaccination was 91.1 percent effective in preventing symptomatic COVID-19 infection throughout six months of follow-up.

A sample of research participants was tracked for six months to look at vaccination safety results. The FDA's prescription instructions will include a warning for a tiny but elevated risk of two inflammatory heart diseases, myocarditis and pericarditis. Boys under the age of 40 are at greater risk, as are males aged 12 to 17. Data on safety will be gathered and maintained indefinitely.

The FDA also visited vaccine production sites before issuing full approval to guarantee vaccine quality. Full approval allows clinicians to prescribe the vaccine for "off-label" use.

Since the Pfizer/BioNTech vaccine gained EUA in December 2020, more than 92 million people in the United States have been fully vaccinated. Under EUA status, children aged 12 to 15 years will continue to get the vaccination.

During public health emergencies, the FDA may award EUA designation if they find that the known and prospective benefits of a medicinal product — in this case, the COVID-19 vaccination — outweigh the known and potential dangers.

SOCIAL DISTANCE, WASHING YOUR HANDS, AND OTHER PREVENTATIVE STEPS

Many of us are now taking precautions to protect ourselves against illness. This most likely entails frequent handwashing, sanitizing commonly touched surfaces regularly, and Social Distance. But are there many things more you can do to help slow the spread of this virus? How can each of these steps assist slow the reach of this virus?

IF YOU ARE AT GREATER RISK

Though no one is invulnerable, we have found that older individuals are at a higher risk of serious disease or death from COVID-19. This is because underlying diseases such as heart disease, lung disease, and diabetes raise risk much more in the elderly. Furthermore, regardless of age, everyone who has an underlying medical problem is at a higher risk of severe disease.

IF YOU HAVE BEEN POSITIVE TO COVID-19, ARE ILL, OR ARE CARING FOR SOMEONE WHO HAS.

Do your best; you may become infected with COVID-19 after being exposed to Coronavirus? You might also be in the situation of caring for a loved one who has the condition. It is critical to understand what to do if you find yourself in any of these scenarios. Stock up on drugs and health supplies now, and understand how to prevent infecting others in your home and becoming ill yourself if you are caring for someone unwell.

COVID-19 TREATMENTS: WHAT WORKS, WHAT DOESN'T, AND WHAT'S ONGOING?

While there are currently no particular therapies for COVID-19, there are certain things you may take to feel better if you become unwell. Meanwhile, researchers worldwide are examining current medicines to determine if they are effective against the virus that causes COVID-19 and attempting to create new therapies.

CORONAVIRUS AND CHILDREN

So far, adults have been the victims of the great majority of coronavirus infections. When children are affected, the illness is usually milder. Still, as parents, you can't help but be concerned about your children's safety. Many parents are also attempting to balance answering their children's inquiries about the epidemic and enforcing health-promoting practices and social distancing regulations without instilling worry in their children. Not to mention keeping children occupied and entertained when schools are closed, and playdates are canceled.

MANAGING CORONAVIRUS

The news concerning Coronavirus and its effects on our daily lives has been relentless. There are causes for alarm, and it is prudent to take the epidemic seriously. However, being on high alert all of the time is not beneficial for your mind or body. This will exhaust you both emotionally and physically.

MORE FRESH INQUIRIES AND RESPONSES

The news concerning Coronavirus and its effects on our daily lives has been relentless. There are causes for alarm, and it is prudent to take the epidemic seriously. However, being on high alert all of the time is not beneficial for your mind or body. This will exhaust you both emotionally and physically.

WHAT ARE THE GREATEST AND LEAST EFFECTIVE FORMS OF MASKS?

Wearing masks has been shown to help reduce coronavirus transmission by preventing droplets and tiny particles known as aerosols that are generated when someone coughs, sneezes, talks, or breathes. But which masks are the finest and which are the worst? A properly fitting surgical mask is the best solution for the general public and should be used whenever feasible.

Duke University researchers devised a basic setup that allowed them to count the number of droplet particles produced when participants repeated "Stay well, people" five times in a row. Participants in the study first spoke without a mask and then repeated the exact phrases while wearing 14 various face masks and covers.

As predicted, medical-grade N95 masks worked best, allowing the fewest droplets to get through. Following them were surgical masks. Several polypropylene masks, a cotton/propylene hybrid, and two-layer cotton masks stitched in various designs also functioned well.

Gaiters came in dead last. Gaiters, sometimes known as neck fleeces, are lightweight garments that athletes frequently use. Bandanas fared poorly as well.

Although the CDC advises masks with two or more layers of washable, breathable fabric, surgical masks are more efficient at filtering out tiny particles than cloth masks. Whatever mask you use, ensure sure it completely covers your nose and mouth and fits securely on the sides of your face without any gaps.

THE CDC OFFERS INSTRUCTIONS ON HOW TO MAKE YOUR MASK FIT BETTER.

IS THERE A MEDICATION THAT MIGHT LOWER MY CHANCES OF GETTING HOSPITALIZED IF I ACQUIRE COVID-19?

Merck will disclose encouraging research findings for an oral antiviral medication to treat COVID-19 in October 2021. In patients with mild or moderate COVID-19 at high risk of severe COVID, the antiviral medication molnupiravir substantially decreased the risk of hospitalization and mortality compared to placebo. As a result, Molnupiravir, if authorized or approved by the FDA, will be the first COVID-19 therapy that may be given orally early in the course of infection to minimize disease severity.

The research's findings were based on data collected from 775 study participants from the United States and throughout the world. Participants had to be diagnosed with mild-to-moderate COVID-19, have started experiencing symptoms no more than five days before participation in the trial, and have at least one risk factor that put them at greater risk for a bad outcome COVID-19 to be eligible for the study. None of the individuals were hospitalized when they enrolled in the research. Approximately half of the research participants got the antiviral medication molnupiravir, which was administered orally in the form of 4 capsules twice a day for five days. The remaining individuals in the trial were given a placebo.

Patients using molnupiravir were half as likely as those taking a placebo to be hospitalized or die from COVID-19. During the 29-day trial period, 28 of 385 individuals, or 7.3 percent, who took molnupiravir were hospitalized, although no one died in this group. Conversely, 53 out of 377 people, or 14.1%, were hospitalized in the placebo group, with eight of these participants dying. The antiviral medication proved effective against several COVID variations, including the Delta form.

The trial was randomized, placebo-controlled, and double-blind, which is considered the gold standard in research design. The reports were announced in a press release without being subjected to peer review or publication in a peer-reviewed medical journal. The press statement said that the risk of adverse events and medication side effects was comparable in the molnupiravir and placebo groups.

Merck and Ridgeback Biotherapeutics collaborated to develop molnupiravir. It operates by interfering with the capacity of the COVID virus to reproduce.

When administered early in the course of illness, another medication, remdesivir (Veklury), can similarly lower the chance of hospitalization. Remdesivir, on the other hand, must be administered intravenously in a medical environment.

The potential of an oral antiviral to treat COVID-19 is intriguing, but it is not a replacement for vaccination. On the contrary, the COVID vaccination is more crucial than ever before. We require many layers of security against this infectious danger. Molnupiravir, hopefully, will be part of that defense.

I JUST MET SOMEONE WHO HAD TESTED POSITIVE WITH COVID-19. I'M FULLY IMMUNIZED. IS IT NECESSARY TO BE TESTED?

You do, indeed (CDC) advised in July 2021 that everyone who is completely vaccinated and comes near or into contact with someone who has or is optimistic of having COVID-19 be tested three to five days following exposure. You must wear a mask in public indoor and outdoor settings for 14 days or negative test results. You don't need to quarantine if you have been vaccinated, but you should isolate if you develop symptoms or obtain a positive test result.

Previously, the CDC stated that someone who had been wholly vaccinated only needed to be checked after exposure if they had symptoms. The adjustment is in response to new information about the Delta variation, which indicates that persons who have been vaccinated and subsequently get ill (breakthrough infections) can spread the virus to others, possibly to the same amount as those who have not been vaccinated.

If you haven't been completely immunized, a 14-day quarantine is the best approach to avoid transmitting the virus to others after being exposed to someone with COVID-19. However, you may exit quarantine after a minimum of 10 days if you have no symptoms or after seven days if you have a negative COVID test within 48 hours of when you intend to end quarantine.

WHAT SHOULD I NEED TO KNOW ABOUT THE DELTA VARIANT?

The Delta form differs from earlier SARS-CoV-2 versions that have arrived in the United States. It's very infectious and can lead to more serious illness. It is also more likely than earlier versions to be transmitted by vaccinated persons who get infected again.

The evidence given to the CDC demonstrated that the Delta variation was far more infectious than earlier variants, with a risk of transmission comparable to chickenpox. It also indicates that infected persons can spread the virus for extended periods.

Furthermore, persons who have been vaccinated and subsequently get ill (breakthrough infections) can spread the virus to others, possibly to the same amount as those who have not been vaccinated. This is also novel; before, vaccinated individuals were far less likely to disseminate prior variations.

Finally, worldwide research indicates that the Delta variation is more likely to induce serious illness.

The good news is that while immunization may be less efficient in preventing Delta variant infection and transmission, it is still highly protective against severe illness, hospitalization, and death. If you haven't already, get the COVID-19 vaccination.

In July 2021, the CDC urged all individuals — vaccinated and unprotected — to wear masks in public indoor and outdoor spaces in parts of the country where the virus was spreading at a high rate. Given the threat posed by the Delta variety, it's fair for everyone to start wearing masks in indoor public areas, regardless of virus level.

Masks decrease the amount of virus we inhale and exhale. When combined with the vaccination, Masks give a one-two punch that decreases the chance of transmission – to children who are not yet permitted for immunizations, individuals with weaker immune systems, and others who are unvaccinated. Masks also offer additional protection to the wearer, even if they are completely vaccinated.

WHY DOES THE CDC REQUIRE FULLY VACCINATED PERSONS TO WEAR MASKS ONCE MORE? WHEN AND WHERE DO I NEED TO PUT ON A SHOW NOW?

In July 2021, the CDC urged all individuals — vaccinated and unprotected — to wear masks in public indoor and outdoor settings where there is a significant or high viral transmission. The CDC has long encouraged unvaccinated persons to wear masks indoors and anybody at higher risk, regardless of the degree of community transmission. The change in advice for those completely vaccinated comes amid an increase in illnesses and hospitalizations across the country.

The emergence of the Delta variation, which spreads more quickly than other variants, is one factor driving the surge in infections. The Delta version of Covid19 is presently the most common in the United States.

We know that persons who have received all of their vaccines have a substantially lower chance of becoming ill if exposed to the Delta version. While the Delta variety is less likely to transmit the virus, it is more competent than the original virus of entering cells that border the nose, mouth, and throat. Once within the cells, these variations rapidly replicate, raising what is known as the viral load. As a result, even those who have been completely vaccinated might harbor higher levels of the Delta form, making it more likely that they will spread the virus to others.

This is where the updated masking guidelines come into play. Masks decrease the amount of virus we inhale and exhale. Thus, when combined with the vaccination, Masks give a one-two punch that reduces the chance of transmission – to children who are not yet permitted for immunizations, individuals with weaker immune systems, and others who are unvaccinated.

Masks also give extra protection to people who use them, even if they are completely vaccinated. Vaccination has proven to be highly successful in preventing severe infection, hospitalization, and death, even against the Delta form. On the other hand, the Delta version has resulted in a handful of breakthrough infections in persons who have been completely vaccinated, and masks give an additional layer of protection.

TERMS TO KNOW ABOUT VIRUS

AEROSOLS: are infectious virus particles that may float or drift in the air. Even if they have no symptoms, a person infected with Coronavirus emits aerosols when they talk, breathe, cough, or sneeze. Someone else may inhale these aerosols and become infected with the virus. Coronavirus aerosols can linger in the air for up to three hours. A mask can help prevent the transmission of bacteria.

ANTIBODIES: are proteins that the immune system produces to help it fight infections. If the antibodies are exposed to the same circumstances again, they can help to prevent illness by recognizing the bacteria and stopping it from entering cells.

AN ANTIBODY TEST: also known as a serologic test, is a blood test that searches for antibodies produced by your immune system. An antibody test can tell you whether you’ve been infected before, but it can’t tell you if you’re sick right now.

AN ANTIGEN is a matter found on the surface of a microorganism that activates the body’s immunological response. 

AN ANTIGEN TEST: is a diagnostics test that identifies particular proteins on the virus’s surface.

COMMUNITY SPREAD (COMMUNITY TRANSMISSION): occurs when people become sick without being aware of any interaction with someone who has the same virus.

CONTACT TRACING: This is a procedure that begins with identifying everyone with whom a person diagnosed with a certain ailment (in this case COVID-19) has had contact since becoming infectious. People who share the person’s residence and those in the same area at the same time as the person with COVID-19 — for example, a school, office, restaurant, or doctor’s office — are warned that they are in danger. If contacts begin to exhibit symptoms, they may be quarantined or requested to separate themselves, and they are more likely to be tested for Coronavirus.

CONTAINMENT: Limiting the spread of disease is referred to as containment. Because there are no vaccinations to prevent COVID-19 and no particular treatments for curing it, containment is accomplished through public health initiatives. These may involve identifying and isolating people who are unwell, as well as tracing down and perhaps quarantining everyone with whom they have had contact.

THE DIAGNOSTIC: test determines whether or not you are presently infected with COVID-19. First, a swab of your nose, nose, throat, or saliva is used to acquire a sample. Next, the sample is examined for viral genetic material (PCR test) or particular viral proteins (antigen test).

EFFECTIVENESS: The efficacy of vaccination in the actual world is shown by its usefulness.

EFFICIENCY: In the context of a clinical trial, effectiveness refers to the advantage of vaccination over a placebo.

EPIDEMIC: A disease outburst in a community or region is referred to as an epidemic.  

FLATTENING THE CURVE: The epidemic curve is a statistical figure used to depict the number of new cases over a particular period during a disease outbreak. Flattening the curve is a colloquial term for adopting mitigation techniques to slow things down so that fewer new cases emerge over a more extended period. This improves the likelihood that hospitals and other healthcare institutions will be prepared to handle any rise in patient volume.

FALSE NEGATIVE: a test result that incorrectly shows that you are not infected when, in fact, you are.

A FALSE-POSITIVE: test result implies that you are infected when you are not.

HERD IMMUNITY: This happens when many people develop immunity to a disease, making its transmission improbable. As a consequence, the entire community is protected, including individuals who are not immune. Herd immunity is often obtained by vaccination, although it can also develop naturally.

IMMUNITY: partial or total protection from a certain infection due to having experienced that infection earlier or being vaccinated against it.

INCUBATION PERIOD The incubation period is the interval between the discovery of infection and the onset of symptoms. 

ISOLATION: the separating of those who have a contagious sickness from others who are not.

LONG-HAULERS: are those who have not entirely healed from COVID after 19 weeks or even months of symptoms.

MITIGATION: Steps done to lessen the impact of disease are referred to as mitigation. Because there are no vaccines to prevent COVID-19 and no specific therapies for treating it, handwashing often and thoroughly, not touching your face, avoiding ill individuals, social Distance, avoiding big gatherings, and routinely cleaning commonly touched surfaces and objects at home, schools, work, and other places are some mitigating methods.

MUTATION: A change in a virus’s genetic material that happens during replication. The transformation is transmitted down to subsequent generations of the virus.

MONOCLONAL ANTIBODIES are proteins created in a lab to resemble naturally occurring antibodies that target particular antigens on viruses, bacteria, and cancer cells.

mRNA: An abbreviation for messenger ribonucleic acid, mRNA is the genetic material that includes instructions for the production of proteins.

mRNA VACCINES: COVID-19 mRNA vaccines include synthesized mRNA. The mRNA enters the body and instructs human cells to make the “spike” protein present on the surface of the Coronavirus. The body recognizes the spike protein as an invader, and antibodies are produced against it. If the antibodies eventually contact the virus, they will detect and eliminate it before it causes sickness.

A PANDEMIC is a Viral disease that affects many people or an entire area, country, or continent.

PHYSICAL DISTANCE: Social Distancing refers to measures used to prevent or halt the transmission of a dangerous disease. It refers to keeping a sufficient physical distance (at least six feet) between oneself and another person to decrease the danger of breathing in droplets or aerosols created when an infected person breathes, talks, coughs, or sneezes.

A POLYMERASE CHAIN REACTION (PCR) TEST identifies the presence of the virus’s genetic material.

POST-VIRAL SYNDROME COVID-19 long truckers develop a constellation of symptoms known as post-viral syndrome. Some of the symptoms include brain fog, fatigue, shortness of breath, chills, body discomfort, headache, joint pain, chest pain, cough, and persistent loss of taste or smell presumptive POSITIVE TEST RESULT for the virus that causes COVID-19 done by a local or state health laboratory is deemed “presumptive” until the CDC verifies it. People with a presumed positive test result will be deemed infected while waiting for confirmation.

QUARANTINE: isolates and limits mobility of persons who have a contagious disease, exhibit symptoms compatible with the disease, or have been exposed to an infectious disease to see if they grow ill.

SARS-COV-2: An abbreviation for acute severe respiratory syndrome coronavirus 2, SARS-CoV-2 is the official name for the virus that causes COVID-19.

SOCIAL DISTANCE: sometimes known as physical separation, refers to measures to prevent or halt the spread of a dangerous disease. It refers to keeping a sufficient physical distance (at least six feet) between oneself and another person to decrease the danger of breathing in droplets or aerosols created when an infected person breathes, talks, coughs, or sneezes. Through phone conversations, video chats, and social media platforms, it is feasible to retain social ties while socially separating.

SPIKE PROTEIN: a protein on the SARS-CoV-2 virus’s surface attaches to and permits the virus to enter human cells.

A VARIANT virus has one or more mutations that distinguish it from a previously circulating version of the virus. Concerning SARS-CoV-2 viral variants: SARS-CoV-2 viruses have mutations that make them more likely to spread, escape vaccinations, or make patients worse.

A VECTOR is a non-harmful capsule. For example, a vector may be used in vaccination to transport a chemical into the body to elicit an immunological response.

VIRUSES are the tiniest infectious organisms, smaller than bacteria or fungi. A virus is made up of a tiny amount of genetic material (DNA or RNA) encased in a protein shell. Viruses cannot duplicate in the absence of a live cell. When a virus infects a live cell (the host cell) and takes over its inner workings, it cannot carry out its usual life-sustaining functions. Instead, the host cell transforms into a virus production machine, producing viral pieces that are subsequently reassembled into full viruses that infect additional cells. The host cell eventually dies.

PRE-HEALING FOR STRENGTHENS THE IMMUNE SYSTEM AND MAKES POWERFUL ANTIBODIES

When we have a poor immune system and weak antibodies, we are affected quickly by any illness. SAMDA AND HMF Can Help Reactivate Our Natural Healing System of Our Body to Help in becoming and live Healthily. 

Pre-Healing with SAMDA HEALING ENERGY and HMF can strengthen and boost our immune system to fight any illness. We received many success stories about corona patients where someone got a positive test of COVID-19, and in the same family, our students are not affected.

Now is the moment to get these PRICELESS COURSES for yourself, your family, and your loved ones and protect them from illnesses like Chronic Psychological Issues, Physical Diseases, Spiritual Problems, Educational Problems, Children Problems, Behavior Problems, and Relationship Problems, etc…

For additional information, DON’T HESITATE TO GET IN TOUCH WITH US: We are always available to help you.

INFORMATION SOURCES Harvard Medical School

 

Disclaimer:

This website's content (text, graphics, photos, and information) is solely for educational purposes. This website provides no assurances about the accuracy of the content, which may change without notice. Therefore, you should always check information from other sources and discuss any medical problem or treatment with your physician/doctor.